Approval · Notice of Compliance 9797 · 2008
RIFATER: Notice of Compliance 9797
Issued September 24, 2008
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 9797
- Date
- September 24, 2008
- Company
- Sanofi-Aventis Canada Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Safety update to the product monograph
- Therapeutic class
- Antituberculous antibiotic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| RIFATER | Not yet assigned | — |
Medicinal ingredients
- RIFAMPIN 120 MG per TAB
- ISONIAZID 50 MG per TAB
- PYRAZINAMIDE 300 MG per TAB